Deflate Hype About New Auvelity for Depression

December 2022

You’ll hear buzz about new Rx Auvelity for depression...an ER combo of dextromethorphan 45 mg and bupropion 105 mg given bid.

You might expect bupropion to be the primary active ingredient.

But the manufacturer is actually touting dextromethorphan for its antidepressant effects...as an NMDA receptor blocker.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Devices Help Patients Navigate OTC Hearing Aids
Migraine Put CV Risks With Triptans in Perspective
Cough & Cold Sort Through OTCs for Cough and Cold Symptoms
Diabetes Evaluate Treatments for Kidney Disease and Diabetes
Antidepressants Deflate Hype About New Auvelity for Depression
Education and Training Be Ready to Manage Challenges With Learners
Psoriasis Demystify Systemic Meds for Psoriasis
Lice Comb Through Head Lice Treatments
Antithrombotics Don’t Delay Restarting Anticoagulation for Atrial Fib After a GI Bleed
Practice Get Your Pharmacy “Inspection-Ready”